Researchers at the University of Illinois are collaborating with the Ohio State University and two other organizations to discover new cancer therapies derived from natural sources such as pond scum and plants from tropical rainforests.
UIC will receive nearly $3 million of the $8 million federal grant to complete multiple projects over five years. Along with Ohio State and UIC, Research Triangle Institute in North Carolina and Bristol-Myers Squibb will assist in the projects. The grant is funded by the National Cancer Institute.
Super Foods
Encyclopedia section of medindia gives an introduction to some super foods that help in preventing and controlling cancer
Advertisement
Cyanobacteria, also referred to as blue-green algae or pond scum, is found in nearly every habitat, from oceans to fresh water to bare rocks to soil, and is a source of many unique chemical structures. UIC researchers, led by principal investigator Jimmy Orjala, assistant professor of pharmacognosy, will collect small samples of pond scum throughout the Midwest and grow them in liquid solutions in a temperature-controlled laboratory.
Using methodology he developed to speed up drug discovery from blue-green algae, Orjala will be able to identify pure active compounds at submilligram levels.
![Anti-cancer Therapies may Be Derived from Marine Animals]( "Anti-cancer Therapies may Be Derived from Marine Animals")
A new study suggests that natural products derived from marine animals may have potential use in anti-cancer therapies, and help improve drug delivery.
"Our goal is to discover naturally occurring anticancer lead compounds that will be more effective than currently available cancer chemotherapeutic agents," Orjala said. If any appear promising, the researchers will grow larger amounts for further evaluation.
Steve Swanson, associate professor and assistant head for research in medicinal chemistry and pharmacognosy, leads the team of UIC researchers that will analyze the biological materials for biological activity once they have been extracted from the algae.
The team will employ assays involving key cellular targets such as the proteasome, which is responsible for breaking down proteins in the cell, Swanson said.
"Cancer cells are known to be particularly sensitive to proteasome inhibitors. Another assay is designed to discover agents that inhibit the enzyme histone deacetylase, which plays a key role in gene expression and is often dysregulated in cancer cells," he said.
Should new compounds be discovered that act on these targets, more detailed studies will be conducted to determine exactly how the substance behaves in cells and in animals, Swanson said.
In addition to the cyanobacteria, plant materials from tropical countries collected by Doel Soejarto, professor of pharmacognosy, will also be analyzed. Information found on UIC's NAPRALERT database, which catalogs biological activities of many plant species found throughout the world, will be used in the project.
Source: Newswise
SRM
Anti-cancer Therapies may Be Derived from Marine Animals
A new study suggests that natural products derived from marine animals may have potential use in anti-cancer therapies, and help improve drug delivery.
Advertisement
"Our goal is to discover naturally occurring anticancer lead compounds that will be more effective than currently available cancer chemotherapeutic agents," Orjala said. If any appear promising, the researchers will grow larger amounts for further evaluation.
Steve Swanson, associate professor and assistant head for research in medicinal chemistry and pharmacognosy, leads the team of UIC researchers that will analyze the biological materials for biological activity once they have been extracted from the algae.
The team will employ assays involving key cellular targets such as the proteasome, which is responsible for breaking down proteins in the cell, Swanson said.
"Cancer cells are known to be particularly sensitive to proteasome inhibitors. Another assay is designed to discover agents that inhibit the enzyme histone deacetylase, which plays a key role in gene expression and is often dysregulated in cancer cells," he said.
Should new compounds be discovered that act on these targets, more detailed studies will be conducted to determine exactly how the substance behaves in cells and in animals, Swanson said.
In addition to the cyanobacteria, plant materials from tropical countries collected by Doel Soejarto, professor of pharmacognosy, will also be analyzed. Information found on UIC's NAPRALERT database, which catalogs biological activities of many plant species found throughout the world, will be used in the project.
Source: Newswise
SRM
Genetics for Next-Generation Cancer Therapies
Scientists have identified a new class of genes, called 'cooperation response genes' (CRGs), which can reveal a great deal about cancer cell function and may also help in finding next
Advertisement
 Understanding Cell Division is the Key for Cancer Therapies: ResearcherUnderstand the process of cell division, would open up potential cancer therapies. | Advertisement
|
Advertisement
Recommended Readings
Latest Cancer News
The combination of the personalized cancer vaccine with ACT led to ovarian cancer control in few patients within a span of three months, stated study results.
Uncovering key kinases in tumor growth and invasion is crucial for improving targeted therapies in advanced-stage colorectal cancer.
The study findings validate metal-enhanced photo-oxidation for future metal-based anticancer drugs.
Mutations in 11 genes are linked to aggressive forms of prostate cancer, which may present novel therapeutic and therapy options.
Improved oral health, as indicated by the count of natural teeth and dental appointments preceding the diagnosis, correlated with enhanced head and neck cancer survival rates.
